Novostar Pharmaceuticals Private Limited
About Novostar Pharmaceuticals Private Limited
Data last updated:
Novostar Pharmaceuticals Private Limited is a private limited company based in Ambala, Haryana, India. It operates in the artificial fibres segment of the food and beverages sector. It was incorporated on 01 December 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Haryana, under CIN U24304HR2017PTC071694. Its GSTIN is 06AAFCN8572L1ZW (Haryana).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Amit Sharma and Vibha Sharma.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 74 Jaggi Garden Phase – 2, Ambala, Haryana, India – 134003.
As per the financials filed for FY 2025, the company reported a revenue of ₹57.22 Lakh, a growth of 119% compared to the previous year. For the same year it recorded a net profit of ₹33,661 (net margin 0.6%) and EBITDA of ₹2.13 Lakh (EBITDA margin 3.7%). Revenue has grown at a compounded annual rate (CAGR) of 33% over three years and 18% over five years.
Court records list 6 cases involving the company, including 2 filed by the company and 4 filed against it; 2 cases are pending.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Novostar Pharmaceuticals Private Limited's registered office is in Ambala, Haryana. Its e-mail address is in the company report.
- Email
- Registered Address74 Jaggi Garden Phase – 2, Ambala, Haryana, India – 134003
- IndustryFood And Beverages, Artificial Fibres, Manufacturing
To see the full contact details of Novostar Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Novostar Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Novostar Pharmaceuticals Private Limited, buy the company report.
Financials of Novostar Pharmaceuticals Private Limited
FY 2025 filings availableNovostar Pharmaceuticals Private Limited reported revenue of ₹57.22 Lakh (up 119% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 18% over five years, including 119% growth in the latest year. EBITDA fell 5% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.13 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹33,661 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.7% | ||||
| Net Profit Margin | 0.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Novostar Pharmaceuticals Private Limited, buy the company report.
Board of directors of Novostar Pharmaceuticals Private Limited
Novostar Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Amit Sharma | Director | 01 Dec 2017 | 8 Years 11 Months | Current |
| Vibha Sharma | Director | 08 May 2018 | 8 Years 5 Months | Current |
Peer comparison
Novostar Pharmaceuticals Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Neumorgen Pharmaceuticals Private Limited | ₹57.37 Lakh (FY 2025) | 48.0% | Sahibabad, Uttar Pradesh, India | |||
| Aveza Pharmaceuticals Private Limited | ₹57.37 Lakh (FY 2025) | 34.0% | Jaipur, Rajasthan, India | |||
| Novostar Pharmaceuticals Private Limitedthis company | ₹57.22 Lakh (FY 2025) | ₹33,661 | 0.6% | 119.0% | Ambala, Haryana, India | |
| Capricon Pharmaceuticals Private Limited | ₹57.19 Lakh (FY 2018) | -59.0% | New Delhi, Delhi, India | |||
| Beecan Pharmaceuticals Private Limited | ₹56.75 Lakh (FY 2024) | 283.0% | Chandigarh, India | |||
| Clarianz Pharmaceuticals Private Limited | ₹56.53 Lakh (FY 2022) | -12.0% | Latur, Maharashtra, India |
To see the full peer comparison of Novostar Pharmaceuticals Private Limited, buy the company report.
Legal cases
Novostar Pharmaceuticals Private Limited has 6 court cases on record: 2 filed by Novostar Pharmaceuticals, 4 filed against it. 2 cases are pending and 4 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 3 | 1 | 1 |
| High courts | 3 | 3 | 1 |
Cases on record (5 of 6)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Bombay High Court | Court case (SCN) | Filed against the company by Jenburkt Pharmaceuticals Ltd | Pending |
| Bombay High Court | Court case (COMIP) | Filed against the company by Jenburkt Pharmaceuticals Ltd | Disposed |
| Bombay High Court | Court case (NMCD) | Filed against the company by Jenburkt Pharmaceuticals Ltd | Disposed |
| District court, Ambala, Haryana | Court case (RP) | Filed against the company by an individual | Pending |
| District court, Ambala, Haryana | Cheque dishonour complaint | Filed by the company against M/S Elixir Traders and 1 other | Disposed |
To see the full case history of Novostar Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Novostar Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Novostar Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 06AAFCN8572L1ZW | Haryana | Active | 08 Feb 2018 |
To see the full GST registrations and return filing status of Novostar Pharmaceuticals Private Limited, buy the company report.
Recent activity
Novostar Pharmaceuticals Private Limited has 3 board changes on record since 2017: 2 appointments and 1 cessation. The latest: Arun Walia ceased to be Director on 18 May 2018.
Frequently asked questions
Novostar Pharmaceuticals is an active private limited company based in Ambala, Haryana, India. The company works in artificial fibres, within the food and beverages industry. It was incorporated on 01 December 2017 (9+ years old) and is registered under CIN U24304HR2017PTC071694.
Novostar Pharmaceuticals has 2 current directors:
- Amit Sharma - Director
- Vibha Sharma - Director
The latest financial statements of Novostar Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Novostar Pharmaceuticals is 06AAFCN8572L1ZW, registered in Haryana.
The CIN (Corporate Identification Number) of Novostar Pharmaceuticals is U24304HR2017PTC071694. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Novostar Pharmaceuticals has 6 court cases on record: 2 filed by the company and 4 filed against it. 2 are pending. Most are in the district courts.
Novostar Pharmaceuticals was incorporated on 01 December 2017, making it 9+ years old. It is registered with the Registrar of Companies, Haryana.
The peers of Novostar Pharmaceuticals by revenue are Neumorgen Pharmaceuticals Private Limited, Aveza Pharmaceuticals Private Limited, Capricon Pharmaceuticals Private Limited, Beecan Pharmaceuticals Private Limited, Clarianz Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Arun Walia ceased to be Director on 18 May 2018. Vibha Sharma was appointed as Director on 08 May 2018. Amit Sharma was appointed as Director on 01 Dec 2017.
The registered office of Novostar Pharmaceuticals is at 74 Jaggi Garden Phase – 2, Ambala, Haryana, India – 134003.
Novostar Pharmaceuticals operates in the food and beverages industry, in the artificial fibres segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
